氧化应激
活性氧
烟酰胺腺嘌呤二核苷酸磷酸
NADPH氧化酶
骨关节炎
软骨细胞
化学
软骨
氧化磷酸化
PLGA公司
人口
细胞生物学
细胞凋亡
体内
活力测定
生物物理学
氧化酶试验
药理学
生物化学
癌症研究
医学
生物
酶
病理
解剖
体外
替代医学
环境卫生
作者
Hyo Jung Shin,Hyewon Park,Nara Shin,Hyeok Hee Kwon,Yuhua Yin,Jeong-Ah Hwang,Song I Kim,Sang Ryong Kim,Soo-Il Kim,Yong Bum Joo,Youngmo Kim,Jinhyun Kim,Jaewon Beom,Dong Ho Kim
出处
期刊:Polymers
[MDPI AG]
日期:2020-02-13
卷期号:12 (2): 443-443
被引量:38
标识
DOI:10.3390/polym12020443
摘要
Osteoarthritis (OA) is the most common joint disorder that has had an increasing prevalence due to the aging of the population. Recent studies have concluded that OA progression is related to oxidative stress and reactive oxygen species (ROS). ROS are produced at low levels in articular chondrocytes, mainly by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and ROS production and oxidative stress have been found to be elevated in patients with OA. The cartilage of OA-affected rat exhibits a significant induction of p47phox, a cytosolic subunit of the NADPH oxidase, similarly to human osteoarthritis cartilage. Therefore, this study tested whether siRNA p47phox that is introduced with poly (D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (p47phox si_NPs) can alleviate chondrocyte cell death by reducing ROS production. Here, we confirm that p47phox si_NPs significantly attenuated oxidative stress and decreased cartilage damage in mono-iodoacetate (MIA)-induced OA. In conclusion, these data suggest that p47phox si_NPs may be of therapeutic value in the treatment of osteoarthritis.
科研通智能强力驱动
Strongly Powered by AbleSci AI